Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

Table 2

The level of serum Cys-C in whole BUT patients.

Parameters	Number of patients	Cys-C	P
		levels (mg/L, mean ± SD)
Age			0.013
<60 yr.	167
≥60 yr.	258
Sex			0.704
Male	344
Female	81
Smoking history			0.153
Never	277
Ever	148
Painless macroscopic hematuria			0.928
No	89
Yes	336
WBC count			0.553
<6.1 × 10^9/L	209
≥6.1 × 10^9/L	216
PLT count			0.525
<213 × 10^9/L	212
≥213 × 10^9/L	213
PFL			0.030
<2.9 g/L	200
≥2.9 g/L	224
Tumor number			0.095
Single	291
Multiple	134
Tumor size			0.378
<2 cm	124
≥2 cm	299
Pathological characteristics			0.156
Papilloma	27
PUNLMP	67
BUC	331
Grade			0.836
Low-grade	180
High-grade	151
Stage			0.783
Ta	178
T1	91
T2	34
T3	17
T4	11

Continuous variables are expressed as median . Bold values are statistically significant (). PUNLMP: papillary urothelial neoplasm of low malignant potential; BUC: bladder urothelial carcinoma; WBC: white blood cell; PLT: platelet; PFL: plasma fibrinogen levels.